Breast Cancer Stem Cells May Be Key to Multi-drug Resistance – 3
Narrator: This is NIH Health Matters. Cancer stem cells may be key to anti-cancer drug resistance. Dr. Michael Gottesman, the director of clinical research at the National Cancer Institute, is leading a study on cancer stem cells. He explains that the study approach has been to catalog all the ways in which cancer cells can become resistant to drugs.
Dr. Gottesman: And then develop cocktails of treatments that can circumvent that resistance; or find certain themes that are common for most cancers, and that can lead to new ways of treating cancer.
Narrator: Dr. Gottesman adds that findings from this study could lead to new drugs and personalized therapies. For details on cancer stem cells and drug resistance, visit www.cancer.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.